In:
Chemistry International, Walter de Gruyter GmbH, Vol. 44, No. 1 ( 2022-01-01), p. 19-21
Kurzfassung:
Drug discovery and development is an expensive, complex, and time-consuming task [5]. Recently, the development of artificial intelligence (AI) approaches to drug discovery, specifically de novo drug design through the use of deep generative models, has triggered a lot of interest in the drug hunter community, especially as an important tool to speed up the process [6].
Materialart:
Online-Ressource
ISSN:
1365-2192
,
0193-6484
DOI:
10.1515/ci-2022-0106
Sprache:
Englisch
Verlag:
Walter de Gruyter GmbH
Publikationsdatum:
2022
ZDB Id:
2053571-5